Wednesday, February 28, 2024
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Chinese scientists highlight the social impact of Cuban medicine

Beijing, Aug 5 (Prensa Latina) Chinese scientists highlighted the social impact in China of Nimotuzumab, Cuba's humanized monoclonal antibody approved for the treatment of pancreatic cancer.

On behalf of the Chinese Society of Clinical Oncology, Dr. Qin Shukui thanked the Sino-Cuban joint venture Biotech Pharma (BPL) for expanding the application of this drug here, beyond the therapy against nasopharyngeal cancer.

According to the researcher, the positive results of the Nimotuzumab clinical trial may benefit more patients with this type of cancer.

According to the doctor, despite the commonness of this condition, the results of treatment at a global level are very poor, that is why new advances are urgently needed and there is a great unmet clinical need.

He also praised the Cuban Academy of Sciences and the importance of the biomedical industry on the island.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.